InsiderClue
Insiders · Profile

Sethuraman Natarajan

President, Research & Develop. at Entrada Therapeutics. Filing since 17 Apr 2023. CIK 0001873394

Company
Date
Role
Action
Shares
Amount
Of holding
TRDA Entrada Therapeutics, Inc.
4 May 2026
President, Research & Develop.
Sold on a plan
25,907
$398.81K
10.7%
TRDA Entrada Therapeutics, Inc.
3 Dec 2024
President, Research & Develop.
Sold on a plan
11,703
$235.79K
7.5%
TRDA Entrada Therapeutics, Inc.
2 Dec 2024
President, Research & Develop.
Sold on a plan
4,088
$82.83K
2.5%
TRDA Entrada Therapeutics, Inc.
29 Nov 2024
President, Research & Develop.
Sold on a plan
100
$2.00K
0.1%
TRDA Entrada Therapeutics, Inc.
13 Nov 2024
President, Research & Develop.
Sold on a plan
2,700
$54.11K
1.7%
TRDA Entrada Therapeutics, Inc.
11 Nov 2024
President, Research & Develop.
Sold on a plan
1,409
$28.19K
0.9%
TRDA Entrada Therapeutics, Inc.
6 Nov 2024
President, Research & Develop.
Sold on a plan
12,299
$231.78K
6.9%
TRDA Entrada Therapeutics, Inc.
5 Nov 2024
President, Research & Develop.
Sold on a plan
5,171
$94.01K
2.8%
TRDA Entrada Therapeutics, Inc.
4 Nov 2024
President, Research & Develop.
Sold on a plan
749
$13.50K
0.4%
TRDA Entrada Therapeutics, Inc.
16 Oct 2024
President, Research & Develop.
Sold on a plan
600
$10.80K
0.3%
TRDA Entrada Therapeutics, Inc.
9 Sep 2024
Chief Scientific Officer
Sold on a plan
2,642
$39.86K
1.4%
TRDA Entrada Therapeutics, Inc.
6 Sep 2024
Chief Scientific Officer
Sold on a plan
600
$9.14K
0.3%
TRDA Entrada Therapeutics, Inc.
15 Jul 2024
Chief Scientific Officer
Sold on a plan
638
$11.48K
0.3%
TRDA Entrada Therapeutics, Inc.
12 Jul 2024
Chief Scientific Officer
Sold on a plan
600
$10.80K
0.3%
TRDA Entrada Therapeutics, Inc.
20 May 2024
Chief Scientific Officer
Sold on a plan
9,675
$146.94K
4.8%
TRDA Entrada Therapeutics, Inc.
17 May 2024
Chief Scientific Officer
Sold on a plan
8,305
$125.75K
4.0%
TRDA Entrada Therapeutics, Inc.
16 May 2024
Chief Scientific Officer
Sold on a plan
1,000
$15.00K
0.5%
TRDA Entrada Therapeutics, Inc.
11 Jul 2023
Chief Scientific Officer
Sold on a plan
14,852
$267.92K
8.8%
TRDA Entrada Therapeutics, Inc.
10 Jul 2023
Chief Scientific Officer
Sold on a plan
3,026
$54.47K
1.8%
TRDA Entrada Therapeutics, Inc.
17 Apr 2023
Chief Scientific Officer
Sold on a plan
3,961
$71.32K
2.3%
20 decisions on file.